ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Odyssey Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$18.10+0.93 (+5.42%)
Close on Oct 19, 2026
- Market cap
- $548.01M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
72.4%
35M of 48M shares
Institutional holders
58
58 new, 0 sold out
Net institutional buying
35M
In Q2 2026
Insider trades, 12 months
9 buys · 3 sales
Net bought $75.29M
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| FMR LLC | 4,577,262 | 10.20% | 13G (passive) | May 29, 2026 |
| Simeon George | 3,794,883 | 8.00% | 13D (active) | May 11, 2026 |
| Jon Winkelried | 3,690,146 | 7.80% | 13D (active) | May 11, 2026 |
| Jeito Capital SAS | 3,690,145 | 7.80% | 13D (active) | May 8, 2026 |
| Lightspeed Venture Partners XV-B (Ignite), L.P. | 3,608,443 | 7.60% | 13G (passive) | May 11, 2026 |
| Dimension Management, L.P. | 3,333,516 | 7.10% | 13D (active) | May 8, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ODTX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 5,179,262 | 10.78% | $96.90M | New | 0.00% |
| Sr One Capital Management, LP | 3,794,883 | 7.90% | $71.00M | New | 6.83% |
| Tpg Gp A, LLC | 3,690,146 | 7.68% | $69.04M | New | 1.38% |
| Lightspeed Management Company, L.L.C. | 3,608,443 | 7.51% | $67.51M | New | 2.81% |
| Orbimed Advisors LLC | 3,001,198 | 6.24% | $56.15M | New | 1.04% |
| Sanofi | 1,991,918 | 4.14% | $37.27M | New | 6.98% |
| Deerfield Management Company, L.P. (Series C) | 1,046,139 | 2.18% | $19.57M | New | 0.20% |
| Sands Capital Ventures, LLC | 875,000 | 1.82% | $16.37M | New | 2.67% |
| Hhlr Advisors, Ltd. | 831,656 | 1.73% | $15.56M | New | 1.87% |
| General Catalyst Group Management, LLC | 810,272 | 1.69% | $15.16M | New | 8.04% |
| Affinity Asset Advisors, LLC | 766,346 | 1.59% | $14.34M | New | 0.65% |
| Adage Capital Partners Gp, L.L.C. | 725,000 | 1.51% | $13.56M | New | 0.02% |
| Vanguard Capital Management LLC | 720,440 | 1.50% | $13.48M | New | 0.00% |
| Foresite Capital Management V, LLC | 713,105 | 1.48% | $13.34M | New | 3.68% |
| Vivo Capital, LLC | 575,000 | 1.20% | $10.76M | New | 0.98% |
| EcoR1 Capital, LLC | 555,555 | 1.16% | $10.39M | New | 0.51% |
| Logos Global Management LP | 521,736 | 1.09% | $9.76M | New | 0.42% |
| Marshall Wace, Llp | 492,697 | 1.03% | $9.22M | New | 0.01% |
| Price T Rowe Associates Inc /Md/ | 471,987 | 0.98% | $8.83K | New | 0.00% |
| Catalio Capital Management, LP | 457,839 | 0.95% | $8.57M | New | 1.61% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 58 | 35M | 72.4% | 58 / 0 | 0 / 0 | 35M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ODTX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Growth Company Fund | 595,900 | 1.24% | $10.14M | 0.01% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 531,096 | 1.11% | $9.94M | 0.00% | Jun 30, 2026 |
| Select Biotechnology Portfolio | 339,500 | 0.71% | $5.77M | 0.11% | May 31, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 182,547 | 0.38% | $3.42M | 0.03% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 179,659 | 0.37% | $3.36M | 0.00% | Jun 30, 2026 |
| Fidelity Growth Company K6 Fund | 164,696 | 0.34% | $2.80M | 0.01% | May 31, 2026 |
| Fidelity Series Growth Company Fund | 147,400 | 0.31% | $2.51M | 0.01% | May 31, 2026 |
| Franklin Biotechnology Discovery Fund | 99,826 | 0.21% | $1.89M | 0.16% | Jul 31, 2026 |
| Schwab Total Stock Market Index Fund | 15,000 | 0.03% | $283.95K | 0.00% | Jul 31, 2026 |
| Vanguard Russell 2000 Index Fund | 11,883 | 0.02% | $202.13K | 0.00% | May 31, 2026 |
| T. Rowe Price Health Sciences Portfolio | 11,276 | 0.02% | $210.97K | 0.03% | Jun 30, 2026 |
| Health Sciences Trust | 7,899 | 0.02% | $147.79K | 0.06% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 6,575 | 0.01% | $123.02K | 0.00% | Jun 30, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 6,442 | 0.01% | $120.53K | 0.00% | Jun 30, 2026 |
| EQ/T.Rowe Price Health Sciences Portfolio | 5,571 | 0.01% | $104.23K | 0.06% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Gary D. Glick | See Remarks, Director | 415,973 | 0.87% | May 11, 2026 |
| Jason Haas | Chief Financial Officer | 62,908 | 0.13% | May 11, 2026 |
| Natalie Dales | See Remarks | 36,880 | 0.08% | May 11, 2026 |
| Anthony W. Opipari | See Remarks | 7,506 | 0.02% | May 11, 2026 |
| Collin M. Todd | See Remarks | – | – | May 11, 2026 |
| Jolie Siegel | See Remarks | – | – | May 7, 2026 |
| Dimension Capital II, L.P. | Director | 512,862 | 1.07% | May 12, 2026 |
| Ian F. Smith | Director | 246,100 | 0.51% | May 11, 2026 |
| Timothy P. Walbert | Director | – | – | May 11, 2026 |
| Jeffrey M. Leiden | Director | 330,540 | 0.69% | May 11, 2026 |
| Nan (LN) Li | Director | 3,333,516 | 6.94% | May 11, 2026 |
| Ourania Tatsis | Director | – | – | May 11, 2026 |
| Valerie Odegard | Director | – | – | May 11, 2026 |
| Shelley Chu | Director | 11,111 | 0.02% | May 11, 2026 |
| Aranicki Ksenija Pavletic | Director | – | – | May 7, 2026 |
| Paulina Hill | Director | – | – | May 7, 2026 |
| Carolyn Ng | Director | 0 | – | May 7, 2026 |
| Jon Winkelried | – | – | – | May 13, 2026 |
| Tpg Gp A, Llc | – | – | – | May 13, 2026 |
| James G. Coulter | – | 3,690,146 | 7.68% | May 13, 2026 |
| Sr One Capital Management, Llc | 10% owner | – | – | May 11, 2026 |
| Simeon George | 10% owner | 2,376,914 | 4.95% | May 11, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| James G. Coulter – | May 11, 2026 | Buy | +1,388,889 | $18.00 | $25.00M | 3,690,146 |
| James G. Coulter – | May 11, 2026 | Conversion | +1,880,497 | – | – | 2,301,257 |
| James G. Coulter – | May 11, 2026 | Other | −2,351 | $18.00 | $42.32K | 420,760 |
| James G. Coulter – | May 11, 2026 | Other | +423,111 | – | – | 423,111 |
| Simeon George 10% owner | May 11, 2026 | Conversion | +139,366 | – | – | 613,414 |
| Simeon George 10% owner | May 11, 2026 | Sale | −438 | $18.00 | $7.88K | 814,851 |
| Simeon George 10% owner | May 11, 2026 | Option exercise | +78,656 | – | – | 815,289 |
| Simeon George 10% owner | May 11, 2026 | Conversion | +273,527 | – | – | 736,633 |
| Simeon George 10% owner | May 11, 2026 | Conversion | +463,106 | – | – | 463,106 |
| Simeon George 10% owner | May 11, 2026 | Buy | +133,333 | $18.00 | $2.40M | 574,314 |
| Simeon George 10% owner | May 11, 2026 | Sale | −277 | $18.00 | $4.99K | 440,981 |
| Simeon George 10% owner | May 11, 2026 | Option exercise | +49,850 | – | – | 441,258 |
| Simeon George 10% owner | May 11, 2026 | Conversion | +166,168 | – | – | 391,408 |
| Simeon George 10% owner | May 11, 2026 | Conversion | +20,582 | – | – | 225,240 |
| Simeon George 10% owner | May 11, 2026 | Conversion | +204,658 | – | – | 204,658 |
| Simeon George 10% owner | May 11, 2026 | Conversion | +255,823 | – | – | 374,335 |
| Simeon George 10% owner | May 11, 2026 | Conversion | +118,512 | – | – | 118,512 |
| Simeon George 10% owner | May 11, 2026 | Buy | +222,222 | $18.00 | $4.00M | 1,831,383 |
| Simeon George 10% owner | May 11, 2026 | Sale | −1,065 | $18.00 | $19.17K | 1,609,161 |
| Simeon George 10% owner | May 11, 2026 | Option exercise | +191,541 | – | – | 1,610,226 |
| Simeon George 10% owner | May 11, 2026 | Conversion | +683,817 | – | – | 1,418,685 |
| Simeon George 10% owner | May 11, 2026 | Conversion | +61,762 | – | – | 734,868 |
| Simeon George 10% owner | May 11, 2026 | Conversion | +59,692 | – | – | 673,106 |
| Simeon George 10% owner | May 11, 2026 | Buy | +200,000 | $18.00 | $3.60M | 1,014,851 |
| Simeon George 10% owner | May 11, 2026 | Conversion | +474,048 | – | – | 474,048 |
| Anthony W. Opipari See Remarks | May 11, 2026 | Option exercise | +541 | – | – | 7,506 |
| Anthony W. Opipari See Remarks | May 11, 2026 | Tax withholding | −4 | $18.00 | $72 | 7,502 |
| Anthony W. Opipari See Remarks | May 11, 2026 | Conversion | +6,965 | – | – | 6,965 |
| Jeffrey M. Leiden Director | May 11, 2026 | Conversion | +28,698 | – | – | 28,698 |
| Jeffrey M. Leiden Director | May 11, 2026 | Tax withholding | −17 | $18.00 | $306 | 31,644 |
| Jeffrey M. Leiden Director | May 11, 2026 | Option exercise | +2,963 | – | – | 31,661 |
| Gary D. Glick See Remarks, Director | May 11, 2026 | Conversion | +27,386 | – | – | 415,973 |
| Nan (LN) Li Director | May 11, 2026 | Buy | +1,111,111 | $18.00 | $20.00M | 3,333,516 |
| Nan (LN) Li Director | May 11, 2026 | Conversion | +1,709,543 | – | – | 2,222,405 |
| Shelley Chu Director | May 11, 2026 | Buy | +11,111 | $18.00 | $200.00K | 11,111 |
| Dimension Capital II, L.P. Director | May 8, 2026 | Buy | +1,111,111 | $18.00 | $20.00M | 3,333,516 |
| Dimension Capital II, L.P. Director | May 8, 2026 | Conversion | +1,709,543 | – | – | 2,222,405 |
| Jeffrey M. Leiden Director | May 8, 2026 | Buy | +5,000 | $20.00 | $100.00K | 270,198 |
| Jason Haas Chief Financial Officer | May 8, 2026 | Buy | +1,000 | $20.00 | $20.00K | 62,908 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.